Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01994148
Other study ID # LGI-201302016
Secondary ID
Status Recruiting
Phase N/A
First received November 11, 2013
Last updated October 8, 2017
Start date January 2014
Est. completion date December 2017

Study information

Verified date October 2017
Source West China Hospital
Contact Zongguang Zhou, MD., PhD.
Phone 18980601007
Email zhou767@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

laparoscopy has been increasingly applied in patients with abdominal trauma , as an diagnostic and therapeutic modality. However, its clinical benefits are still under evaluation. The aim of this study is to prospectively assess the feasibility and safety of this technique in the management of traumatic gastrointestinal injury.


Description:

This prospective single arm study was undertaken in West China Hospital, Sichuan University, Chengdu, China. The institution is the largest medical center in southwest China, and also a national training center of laparoscopy. Surgeons participated in the study were well trained in gastrointestinal laparoscopy and hepatobiliary laparoscopy, and were experienced in management of abdominal trauma.

The study was approved by the institutional review committees. The participants provided written informed consent.

Patients age 18 years or older with abdominal trauma were considered eligible, regardless of the nature of trauma (blunt or penetrating), but hemodynamic stability was mandatory.

Patients meet the following criteria is prepared for laparoscopic exploration:

Evidence showed that wound penetrates the peritoneum in penetrating trauma or/and signs of peritoneal irritation or positive CT scan in those without penetration of peritoneum and patients with blunt injuries.

We defined the CT scan positive by it shows peritoneal effusion, free intraperitoneal air, fat density increase, substantive organ rupture and intestinal wall swelling and other signs of abdominal trauma.

Laparoscopic screening will be performed according to protocol. The study demands that all surgeons should complete the repair laparoscopically as much as possible when condition allow, and record reasons for conversion in detail when it is inevitable.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 2017
Est. primary completion date November 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Clinical diagnosis of gastrointestinal trauma

- Blood loss < 1000ml

- Hemodynamically stable

- Vital sign is stable

- Willing to comply to the study procedure and complete the study.

Exclusion Criteria:

- Severe hemorrhage or intraperitoneal infections

- Combined with other conditions which are contraindications to laparoscopy

- Pregnant or lactating woman

- Severe immunodeficiency

- History of drug abuse

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Laparoscopy
In this study, laparoscopic intervention will be performed under carbon dioxide pneumoperitoneum (pressure, 10-12 mm Hg; flow volume, 8-10 L/min). A 12-mm trocar will be placed in the umbilicus with use of an open technique and to establish pneumoperitoneum.A 10-mm and a 5-mm trocar will be inserted in the right and left flanks,respectively.

Locations

Country Name City State
China Chinese PLS General Hospital Beijing
China West China Hospital, Sichuan University Chengdu Sichuan
China Southwest Hospital, The 3rd Militory Medical University Chongqing
China Xijing Hospital, The 4th Militory Medical University Xian Shanxi

Sponsors (1)

Lead Sponsor Collaborator
Prof. Zongguang Zhou

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mortality 3 month after operation
Secondary Number of iatrogenic injury during the operation at the end of the operation
Secondary Number of patients with postoperative complications Postoperative complications include bowel obstruction, wound infection, postoperative hemorrhage,intestine fistula up to 3 months
Secondary Operative time at the end of the operaion
Secondary Blood loss during the operation at the end of the operation
Secondary Length of hospital stay 1 month
Secondary Number of patients transferred to open operation at the end of the operation
See also
  Status Clinical Trial Phase
Recruiting NCT05226221 - Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality
Completed NCT04111263 - Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude N/A
Completed NCT02127164 - Vacuum Assisted Therapy in Emergent Contaminated Abdominal Surgeries N/A
Completed NCT03198741 - Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation Phase 4
Recruiting NCT05951517 - Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein Purpura N/A
Enrolling by invitation NCT05051358 - Therapeutic Endoscopic Ultrasound for Gastrointestinal Disorders: A Multicenter Registry Study
Recruiting NCT04769830 - Biomarkers and Bowel Sounds in Patients With Acute Gastrointestinal Injury